| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |